Also known as

hGH 177–191 · AOD9604 · Lipolytic GH fragment analog

Overview

AOD-9604 is a modified fragment of the C-terminal region of human growth hormone (residues 177–191) studied in lipolytic and metabolic research without classical GH growth-pathway activation framing.

Catalogs list it among weight-loss / metabolic research tools. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Lipolytic endpoints in adipose research models

• - Metabolic and body-composition markers where studied

• - GH-fragment pharmacology without full GH-receptor growth framing

• - Energy-expenditure co-readouts in preclinical designs

• - Comparative metabolic fragment work versus full GH secretagogues

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

• Week 1–2: Early receptor-engagement and appetite/energy-signaling readouts in model systems; compound exposure establishing.

• - Week 3–4: Clearer metabolic and satiety-pathway markers in short preclinical windows.

• - Month 2–3: More stable body-composition and glucose/lipid-related endpoints where studied.

• - Month 3–6: Sustained metabolic-signaling observations in longer research designs.

Footer RUO

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.